341 related articles for article (PubMed ID: 22095638)
1. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
[TBL] [Abstract][Full Text] [Related]
2. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
[TBL] [Abstract][Full Text] [Related]
3. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study.
Yap SC; Roos-Hesselink JW; Hoendermis ES; Budts W; Vliegen HW; Mulder BJ; van Dijk AP; Schalij MJ; Drenthen W
Eur Heart J; 2007 Aug; 28(15):1854-61. PubMed ID: 17030523
[TBL] [Abstract][Full Text] [Related]
4. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
[TBL] [Abstract][Full Text] [Related]
5. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy.
O'Mahony C; Lambiase PD; Quarta G; Cardona M; Calcagnino M; Tsovolas K; Al-Shaikh S; Rahman SM; Arnous S; Jones S; McKenna W; Elliott P
Heart; 2012 Jan; 98(2):116-25. PubMed ID: 21757459
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot.
Koyak Z; de Groot JR; Bouma BJ; Van Gelder IC; Budts W; Zwinderman AH; Mulder BJ
Int J Cardiol; 2013 Aug; 167(4):1532-5. PubMed ID: 22608897
[TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
[TBL] [Abstract][Full Text] [Related]
10. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study.
Khairy P; Harris L; Landzberg MJ; Fernandes SM; Barlow A; Mercier LA; Viswanathan S; Chetaille P; Gordon E; Dore A; Cecchin F
Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):250-7. PubMed ID: 19808416
[TBL] [Abstract][Full Text] [Related]
11. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
12. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
[TBL] [Abstract][Full Text] [Related]
13. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
[TBL] [Abstract][Full Text] [Related]
14. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
15. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
16. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
Alexander ME; Cecchin F; Walsh EP; Triedman JK; Bevilacqua LM; Berul CI
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):72-6. PubMed ID: 15028076
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
[TBL] [Abstract][Full Text] [Related]
18. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
[TBL] [Abstract][Full Text] [Related]
20. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
